BMI body mass index, BP blood pressure, CABG coronary artery bypass grafting, CAP controlled attenuation parameter, Hb hemoglobin, INR international normalized ratio, MASLD metabolic dysfunction-associated steatotic liver disease, MRI PDFF magnetic resonance imaging proton density fat fraction, n.s. not significant, PEth phosphatidylethanol, T2D type 2 diabetes, VCTE vibration-controlled transient elastography, WBC white blood cell count, ɣGT gamma-glutamyl transferase. This evidence concerns the gene GSTM1 and liver disorder.